通过稳定SEZ6L2表达,IGF2BP2促进NSCLC中的DDP抵抗
Zhuoyu Chen1, Zhaoqiang Yang1, Nan Chen2
1Department of Respiratory Medicine, Shunde Hospital Guangzhou University of Chinese Medicine, Foshan City, China.
Journal of biochemical and molecular toxicology
|August 13, 2025
概括
胰岛素样生长因子2mRNA结合蛋白2 (IGF2BP2) 通过调节SEZ6L2.2.促进了对西斯普拉丁抗性非小细胞肺癌 (NSCLC) 的进展. 向IGF2BP2可能为NSCLC患者提供新的治疗策略.
科学领域:
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
- 药物耐药性机制 药物耐药性机制
背景情况:
- 非小细胞肺癌 (NSCLC) 患者的存活率很低,特别是那些耐西斯丁 (DDP) 的患者.
- 胰岛素样生长因子2和mRNA结合蛋白2 (IGF2BP2) 在DDP耐性NSCLC中的作用仍未明确.
研究的目的:
- 调查IGF2BP2在DDP耐药NSCLC中的机制.
- 确定IGF2BP2的下游目标及其在瘤进展中的作用.
主要方法:
- 定量实时PCR (qRT-PCR) 和西布洛特用于基因和蛋白质表达分析.
- 在体外测试 (CCK-8,殖民地形成,伤口愈合,Transwell,流细胞计,管形成) 来评估细胞行为.
- RNA免疫沉 (RIP),双化酶记者和RNA衰变试验以确认分子相互作用.
- 在体内外移植的小鼠模型来评估瘤生长.
主要成果:
- 在DDP耐性NSCLC中,IGF2BP2的升高调节,与预后不佳相关.
- IGF2BP2的淘汰抑制了增殖,迁移,入侵,血管生成和M2巨细胞的两极分化,同时促进了亡.
- 与发作相关的6类同源像2 (SEZ6L2) 被确定为直接目标,通过m6A甲基化由IGF2BP2调节,并与预后不佳相关.
- SEZ6L2过度表达部分逆转了IGF2BP2敲击的抑制作用.
结论:
- 通过调解SEZ6L2mRNA的m6A甲基化,IGF2BP2促进了DDP抗性NSCLC的进展.
- IGF2BP2和SEZ6L2代表了DDP抗性NSCLC的潜在治疗点.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.5K
12:29Identifying Transcription Factor Olig2 Genomic Binding Sites in Acutely Purified PDGFRα+ Cells by Low-cell Chromatin Immunoprecipitation Sequencing Analysis
Published on: April 16, 2018
9.4K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
